Skip to main content

Table 2 Approach to search and selection of studies for each key question

From: Screening for the primary prevention of fragility fractures among adults aged 40 years and older in primary care: systematic reviews of the effects and acceptability of screening and treatment, and the accuracy of risk prediction tools

 

Key question 1 a & b

(a) Benefits and harms of screening vs no screening

(b) Comparative benefits and harms of screening approaches/ tools

Key question 2

Predictive accuracy of screening tests

Key question 3 a & b

(a) Benefits of pharmacologic treatments

(b) Harms of pharmacologic treatments

Key question 4

Acceptability of screening and/or treatment

Search

Approach

Integration of eligible studies from 2018 USPSTF review, with search from 2016 onward

Integration of eligible studies from 2018 USPSTF review, with search from 2016 onward

KQ3a: integration of eligible studies from 2018 USPSTF review, with search update from 2016 onward

KQ3b: (i) search for reviews from 2015 onward; (ii) search for primary studies on rebound fractures from discontinuation of denosumab from 2020

Search from 1995 (introduction of bisphosphonates)

Search Strategy

See protocol

See protocol

KQ3a: see protocol

KQ3b: Additional file 2

See protocol

Concepts

Bone health, fractures, osteoporosis, screening

Bone health, fractures, osteoporosis, screening tests, risk assessment, prognosis

Osteoporosis, drug treatment, harms (in general and specific harms; KQ3b only)

Bone health, fractures, screening, risk assessment, osteoporosis - diagnosis, prevention, treatment, risk, decision-making, acceptability

Databases

Ovid Medline, Ovid Embase, Wiley Cochrane Library

Ovid Medline, Ovid Embase, Wiley Cochrane Library

Ovid Medline, Ovid Embase (KQ3a only), Wiley Cochrane Library

Ovid Medline, Ovid Embase, Wiley Cochrane Library, PsycINFO

Additional sources

Clinicaltrials.gov; WHO ICTRP; scanned reference lists of systematic reviews, included studies, major guidelines; contacting authors

Clinicaltrials.gov; WHO ICTRP; scanned reference lists of systematic reviews, included studies, major guidelines; contacting authors

KQ3a: Clinicaltrials.gov; WHO ICTRP; scanned reference lists of systematic reviews, included studies, major guidelines; contacting authors

KQ3b: PROSPERO, Epistemonikos

Scanned reference lists of systematic reviews, included studies; contacting authors

Date of search(es)

2016 to 8 July 2019

Update in databases 4 April 2022

2016 to 5 July 2019

Update in databases 1 June 2021

KQ3a: 2016 to 2 March 2020

KQ3b: (i) 2015 to 24 June 2020; (ii) 2020 to 18 June 2021

1995 to 4 July 2019

Update in databases 1 June 2021

Selection

Titles and abstracts

Liberal-accelerated (i.e., only requiring one reviewer to include to full text review)

Liberal-accelerated

KQ3a: liberal-accelerated

KQ3b: single reviewer

Liberal-accelerated

Full Text

Duplicate

Duplicate

KQ3a: duplicate

KQ3b: single reviewer

Duplicate

Final inclusion

By consensus, with consultation of a third reviewer if needed

By consensus, with consultation of a third reviewer if needed

By consensus, with consultation of a third reviewer if needed

Single reviewer, with consultation of a second reviewer if needed

  1. KQ Key question, WHO ICTRP World Health Organization International Clinical Trials Registry Platform, USPSTF United States Preventive Services Task Force